Clinical Trial Update: Real World Data on Ibrutinib Use in PCNSL Rel/Ref

View source ↗

Summary

Real-world data study update on the use of ibrutinib in relapsed or refractory primary central nervous system lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Ibrutinib (ibrutinib)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: PCNSL | Status: ACTIVE_NOT_RECRUITING